GEMS informs policies and defines programmatic considerations related to use of ARV-based HIV prevention products and risk of resistance.
The lab team requested PrEP trials’ samples for assay development work.
The modeling team is adapting the current individual-based HIV Synthesis Transmission model for the project.
The policy team has identified potential members for its Policy and Implementation Steering Committee, which will convene in the coming months.
The roll-out team is researching novel blood collection methods to measure resistance in individuals who seroconvert while on PrEP.
Leave a Reply